| Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives R Castagnoli, OM Delmonte, E Calzoni, LD Notarangelo Frontiers in pediatrics 7, 295, 2019 | 181 | 2019 |
| Inborn errors of immunity with immune dysregulation: from bench to bedside OM Delmonte, R Castagnoli, E Calzoni, LD Notarangelo Frontiers in pediatrics 7, 353, 2019 | 87 | 2019 |
| Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia M Bosticardo, F Pala, E Calzoni, OM Delmonte, K Dobbs, CL Gardner, ... Blood advances 4 (12), 2611-2616, 2020 | 83 | 2020 |
| Natural killer cells from patients with recombinase-activating gene and non-homologous end joining gene defects comprise a higher frequency of CD56bright NKG2A+++ cells, and … K Dobbs, G Tabellini, E Calzoni, O Patrizi, P Martinez, SC Giliani, ... Frontiers in immunology 8, 798, 2017 | 50 | 2017 |
| Efficacy and safety of anti-CD45–saporin as conditioning agent for RAG deficiency MC Castiello, M Bosticardo, N Sacchetti, E Calzoni, E Fontana, ... Journal of Allergy and Clinical Immunology 147 (1), 309-320. e6, 2021 | 34 | 2021 |
| Defining a new immune deficiency syndrome: MAN2B2-CDG J Verheijen, SY Wong, JH Rowe, K Raymond, J Stoddard, OM Delmonte, ... The Journal of allergy and clinical immunology 145 (3), 1008, 2020 | 26 | 2020 |
| F-BAR domain only protein 1 (FCHO1) deficiency is a novel cause of combined immune deficiency in human subjects E Calzoni, CD Platt, S Keles, HS Kuehn, S Beaussant-Cohen, Y Zhang, ... Journal of Allergy and Clinical Immunology 143 (6), 2317-2321. e12, 2019 | 26 | 2019 |
| Agammaglobulinemia associated to nasal polyposis due to a hypomorphic RAG1 mutation in a 12 years old boy C Cifaldi, A Scarselli, D Petricone, S Di Cesare, M Chiriaco, A Claps, ... Clinical Immunology 173, 121-123, 2016 | 10 | 2016 |
| Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia (vol 4, pg 2611, 2020) M Bosticardo, F Pala, E Calzoni, OM Delmonte, K Dobbs, CL Gardner, ... BLOOD ADVANCES 4 (15), 3507-3507, 2020 | 5 | 2020 |
| Targeted Genome Editing of Hematopoietic Stem Cells for Treating Recombination Activating Gene 1 (RAG1) Immunodeficiency MC Castiello, N Sacchetti, E Draghici, S Ferrari, V Vavassori, C Brandas, ... MOLECULAR THERAPY 29 (4), 21-21, 2021 | 1 | 2021 |
| Human inborn errors of immunity caused by defects of receptor and proteins of cellular membrane. E Calzoni, R Castagnoli, SC Giliani Minerva Pediatrica, 2020 | | 2020 |
| A Novel Immunodeficiency Disease Associated With A Congenital Disorder Of Glycosylation: MAN2B2 Deficiency L Notarangelo, J Verheijen, S Wong, J Rowe, K Raymond, J Stoddard, ... JOURNAL OF CLINICAL IMMUNOLOGY 40 (SUPPL 1), S21-S22, 2020 | | 2020 |
| Artificial Thymic Organoids Represent a Reliable and Quick Tool to Study T Cell Differentiation in Human Bone Marrow Samples from Patients with Severe T Cell Immunodeficiency M Bosticardo, F Pala, E Calzoni, C Gardner, K Dobbs, SS De Ravin, ... JOURNAL OF CLINICAL IMMUNOLOGY 39, S51-S52, 2019 | | 2019 |
| Genotype-phenotype Correlation in Human RAG1 Deficiency E Calzoni, E Bello, T Kawai, Y Yamazaki, LD Notarangelo JOURNAL OF CLINICAL IMMUNOLOGY 39, S140-S140, 2019 | | 2019 |
| Rag1 hypomorphic mouse mutants show partial preservation of thymocyte development but peculiar abnormalities of thymic epithelial cell phenotype LO de Bruin, M Bosticardo, Y Yamazaki, E Calzoni, C Corsino, J Manis, ... JOURNAL OF CLINICAL IMMUNOLOGY 38 (3), 430-431, 2018 | | 2018 |
| Conditioning with anti-CD45 immunotoxin in a mouse model of hypomorphic Rag1 deficiency allows complete reconstitution of the immune system with lack of toxicity E Calzoni, C Corsino, M Bosticardo, Y Yamazaki, HH Yu, LO de Bruin, ... JOURNAL OF CLINICAL IMMUNOLOGY 38 (3), 426-427, 2018 | | 2018 |
| reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia. Blood Adv. 2020; 4 (12): 2611-2616. M Bosticardo, F Pala, E Calzoni | | |
| reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia. Blood Adv. 2020; 4 (12): 2611-2616. M Bosticardo, F Pala, E Calzoni | | |
